SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001306550-23-008587
Filing Date
2023-02-10
Accepted
2023-02-10 14:56:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 us92539p1012_021023.txt SC 13G 11556
  Complete submission text file 0001306550-23-008587.txt   13295
Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Subject) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92605 | Film No.: 23611207
SIC: 2834 Pharmaceutical Preparations